Dossier Writing
Our medical writing, clinical, CMC, and regulatory affairs teams expertly prepare the necessary documentation to support applications throughout all stages of the product lifecycle.
Our Services
Whether you require a complete CTD dossier crafted from scratch or just specific parts or modules, we have you covered.
- Clinical and Nonclinical Overviews/Summaries (Modules 2.4/2.5/2.6/2.7)
- Quality Overall Summaries (Module 2.3) and Module 3 sections
- Active substance master file (ASMF) and drug master file (DMF)
- Addendums to Clinical Overview
- Clinical Overviews / Expert Reports to support classification change (Rx to OTC switch)
- Summaries of product characteristics (SPCs) and Package Leaflets (PL)
- Package Leaflet Readability User Testing (RUT) or Bridging Reports (Module 1.3.4)
- Risk Management Plans (1.8.2)
- CMC Amendments
- Normative documents (for CIS countries)

Facts & Figures
The Numbers Behind Our Success
- 0+ Clinical/Nonclinical overviews written
- 0+ Quality overall summaries written
- 0+ PL Readability user tests/bridging reports performed
FAQ’s
Can't find your question? Contact us, we're here to help!
- What are the timelines for developing Clinical and Nonclinical Overviews/Summaries (Modules 2.4/2.5/2.6/2.7)?
- What is required for an Rx to OTC Classification Change?
- When can I use a Bridging Report (Module 1.3.4) and not do a full Package Leaflet Readability User Testing (RUT)?
- What is the deadline for EAEU MAA upgrade (bringing dossiers into compliance) procedure?
Contact